Home Health Blog May 2026 Malignant Hyperthermia (MH)

Malignant Hyperthermia (MH)

May 27, 2026 Genetic-Testing

A severe reaction to anesthesia can happen without warning. That’s why genetic testing may help prevent unexpected medical emergencies before they happen.

A severe reaction to anesthesia can happen without warning. That’s why genetic testing may help prevent unexpected medical emergencies before they happen.

By Prof. Dr. Chonlaphat Sukasem, Bumrungrad’s pharmacogenomics consultant

For more information please contact:

Last modify: May 27, 2026

Bumrungrad Hospital

Related Packages

CALL FOR APPOINTMENT

SEND AN INQUIRY

BOOK APPOINTMENT

Rating score 0 of 10, based on 0 vote(s)

Genetic-Testing

Related Health Blogs

Newborn Genetic Screening at Bumrungrad: What Every Parent Should Know

Your baby looks perfectly healthy. But some genetic conditions show no signs at birth. They may only appear weeks, months, or even years later. That is why more parents around the world are choosing newborn genetic screening to catch potential health risks early, when treatment works best.

Genetic-Testing

Malignant Hyperthermia (MH): Symptoms, Causes, Prevention

Malignant hyperthermia (MH) is a rare, but severe anesthetic complication triggered by certain medications used during general anesthesia. This condition causes uncontrolled muscle contraction, rapidly rising body temperature, and severe metabolic complications.

Genetic-Testing

Pharmacogenomics The right medication for you… because everyone’s genes are different

Benefits of pharmacogenomics testing Reduce the risk of drug allergies and side effects Select and adjust medications tailored to you Store your genetic profile in your medical record for lifelong reference

Genetic-Testing